Search

Your search keyword '"Lovering, Richard M."' showing total 193 results

Search Constraints

Start Over You searched for: Author "Lovering, Richard M." Remove constraint Author: "Lovering, Richard M."
193 results on '"Lovering, Richard M."'

Search Results

151. CaMKII oxidation is a critical performance/disease trade-off acquired at the dawn of vertebrate evolution.

152. Mss51 deletion increases endurance and ameliorates histopathology in the mdx mouse model of Duchenne muscular dystrophy.

153. Muscle phenotype of a rat model of Duchenne muscular dystrophy.

154. Effects of myofiber isolation technique on sarcolemma biomechanics.

155. Alterations of neuromuscular junctions in Duchenne muscular dystrophy.

156. Engineering 3D skeletal muscle primed for neuromuscular regeneration following volumetric muscle loss.

157. A comparative assessment of lengthening followed by end-to-end repair and isograft repair of chronically injured peripheral nerves.

158. Abnormalities in Brain and Muscle Microstructure and Neurochemistry of the DMD Rat Measured by in vivo Diffusion Tensor Imaging and High Resolution Localized 1 H MRS.

159. Keratin 18 is an integral part of the intermediate filament network in murine skeletal muscle.

160. Mss51 deletion enhances muscle metabolism and glucose homeostasis in mice.

161. Differential YAP nuclear signaling in healthy and dystrophic skeletal muscle.

162. Engineering functional and histological regeneration of vascularized skeletal muscle.

163. Imaging Analysis of the Neuromuscular Junction in Dystrophic Muscle.

164. Non-invasive assessment of muscle injury in healthy and dystrophic animals with electrical impedance myography.

165. mTOR regulates peripheral nerve response to tensile strain.

166. NAD+ repletion improves muscle function in muscular dystrophy and counters global PARylation.

167. Alternating bipolar field stimulation identifies muscle fibers with defective excitability but maintained local Ca(2+) signals and contraction.

168. In Vivo Assessment of Muscle Contractility in Animal Studies.

169. Abnormalities in brain structure and biochemistry associated with mdx mice measured by in vivo MRI and high resolution localized (1)H MRS.

170. Pre- and postsynaptic changes in the neuromuscular junction in dystrophic mice.

171. Myofiber damage precedes macrophage infiltration after in vivo injury in dysferlin-deficient A/J mouse skeletal muscle.

172. SERCA1 overexpression minimizes skeletal muscle damage in dystrophic mouse models.

173. Myopathic changes in murine skeletal muscle lacking synemin.

174. Recovery of altered neuromuscular junction morphology and muscle function in mdx mice after injury.

175. Tetanus toxin preserves skeletal muscle contractile force and size during limb immobilization.

176. Ganglion cyst in the tarsal tunnel.

177. Architecture of healthy and dystrophic muscles detected by optical coherence tomography.

178. Ectopic lipid deposition and the metabolic profile of skeletal muscle in ovariectomized mice.

179. Effects of in vivo injury on the neuromuscular junction in healthy and dystrophic muscles.

180. Structural and functional evaluation of branched myofibers lacking intermediate filaments.

181. An in vivo rodent model of contraction-induced injury in the quadriceps muscle.

182. Genetic deletion of trkB.T1 increases neuromuscular function.

183. Evaluation and imaging of an untreated grade III hamstring tear: a case report.

184. Modulation of sarcoplasmic reticulum Ca2+ release in skeletal muscle expressing ryanodine receptor impaired in regulation by calmodulin and S100A1.

185. Physiology, structure, and susceptibility to injury of skeletal muscle in mice lacking keratin 19-based and desmin-based intermediate filaments.

186. S100A1 promotes action potential-initiated calcium release flux and force production in skeletal muscle.

187. Extensive mononuclear infiltration and myogenesis characterize recovery of dysferlin-null skeletal muscle from contraction-induced injuries.

188. Malformed mdx myofibers have normal cytoskeletal architecture yet altered EC coupling and stress-induced Ca2+ signaling.

189. Use of autologous platelet-rich plasma to treat muscle strain injuries.

190. Architecture and fiber type of the pyramidalis muscle.

191. Recovery of function in skeletal muscle following 2 different contraction-induced injuries.

192. Effect of testosterone on the female anterior cruciate ligament.

193. Contractile function, sarcolemma integrity, and the loss of dystrophin after skeletal muscle eccentric contraction-induced injury.

Catalog

Books, media, physical & digital resources